Illumina Adds Former FDA Commissioner Scott Gottlieb to Its Board of Directors
As Illumina (NASDAQ: ILMN) moves more into the clinical diagnosis space, the DNA-sequencing specialist has made a big addition to its board of directors: Scott Gottlieb, a former commissioner of the Food and Drug Administration. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates as well as a resident fellow at the American Enterprise Institute, a public policy think tank.
Scott Gottlieb. Image source: Business Wire.
Illumina wanted Gottlieb so badly, it expanded its board to 10 members in order to accommodate the former FDA chief. Illumina isn't the first healthcare company to snag Gottlieb. He also serves on the boards of Pfizer, privately held Aetion, and a think tank called FasterCures.
Source Fool.com